Igyxos Biotherapeutics
Pre-clinicalIgyxos Biotherapeutics is harnessing breakthrough science in monoclonal antibodies to pioneer novel therapeutics that aim to transform the treatment of infertility in men and women.
Founded
2020
Focus
AntibodiesBiologics
About
Igyxos Biotherapeutics is harnessing breakthrough science in monoclonal antibodies to pioneer novel therapeutics that aim to transform the treatment of infertility in men and women.
Funding History
1Total raised: $10M
Seed$10MSofinnova PartnersJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile